Aigen Investment Management’s Eli Lilly LLY Stock Holding History

Aigen Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.9M	Buy	+2,071	New	+$2.1M	0.49%	54
2025 Q3	–	Sell	-792	Closed	-$617K	–	954
2025 Q2	$617K	Buy	+792	New	+$615K	0.08%	345
2024 Q4	–	Sell	-1,618	Closed	-$1.43M	–	882
2024 Q3	$1.43M	Buy	+1,618	New	+$1.45M	0.28%	88
2024 Q2	–	Sell	-8,520	Closed	-$6.63M	–	919
2024 Q1	$6.63M	Buy	+8,520	New	+$6.06M	1.44%	1
2022 Q3	–	Sell	-4,693	Closed	-$1.52M	–	681
2022 Q2	$1.52M	Sell	4,693 -5,840	-55%	-$1.75M	0.26%	118
2022 Q1	$3.02M	Buy	10,533 +3,696	+54%	+$951K	0.52%	48
2021 Q4	$1.83M	Buy	+6,837	New	+$1.73M	0.11%	240
2021 Q2	–	Sell	-2,724	Closed	-$509K	–	618
2021 Q1	$509K	Buy	+2,724	New	+$533K	0.07%	287
2020 Q4	–	Sell	-6,586	Closed	-$975K	–	921
2020 Q3	$975K	Buy	+6,586	New	+$1.02M	0.12%	258
2020 Q2	–	Sell	-5,251	Closed	-$728K	–	1087
2020 Q1	$728K	Buy	+5,251	New	+$721K	0.1%	303

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aigen Investment Management's LLY Position: Q1 2026 in Review

Aigen Investment Management opened a new position in Eli Lilly (LLY) in Q1 2026: 2,071 shares worth $1.9M. The stake represents 0.49% of the portfolio and ranks #54 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in LLY as recently as Q2 2025.

Aigen Investment Management first reported a position in LLY in Q1 2020 and has held it in 10 quarters since. The position peaked at $6.63M in Q1 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Aigen Investment Management held 2,071 shares of Eli Lilly worth $1.9M as of Q1 2026.
Eli Lilly was a new Aigen Investment Management position in Q1 2026.
Eli Lilly made up 0.49% of Aigen Investment Management's portfolio in Q1 2026, its #54 holding.
Aigen Investment Management first reported a position in Eli Lilly in Q1 2020 and has held it in 10 quarters since.
Aigen Investment Management's Eli Lilly position peaked at $6.63M in Q1 2024.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.